|
"kang yi su"的相關文件
顯示項目 11-20 / 85 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-11-10T05:33:55Z |
Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models
|
Yu, Sung-Liang; Chu, Selina Shih-Ting; Chien, Min-Hui; PO-HSIU KUO; Yang, Pan-Chyr; KANG-YI SU |
| 臺大學術典藏 |
2021-11-10T05:32:04Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Wu, Shang-Gin; Liao, Wei-Yu; KANG-YI SU; Yu, Sung-Liang; Huang, Yen-Lin; Yu, Chong-Jen; Chih-Hsin Yang, James; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-11-10T05:29:42Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:28:05Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-09-14T23:18:48Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M (Scientific Reports, (2021), 11, 1, (12084), 10.1038/s41598-021-91657-7)
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-09-14T23:18:48Z |
Transthyretin as a biomarker to predict and monitor major depressive disorder identified by whole‐genome transcriptomic analysis in mouse models
|
SUNG-LIANG YU; Chu, Selina Shih Ting; Chien, Min Hui; Kuo, Po Hsiu; PAN-CHYR YANG; KANG-YI SU |
| 臺大學術典藏 |
2021-07-30T01:30:25Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Huang, Yen Lin; Chih-Hsin Yang, James; SHANG-GIN WU; WEI-YU LIAO; KANG-YI SU; SUNG-LIANG YU; CHONG-JEN YU; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-07-21T23:21:30Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
SHANG-GIN WU; WEI-YU LIAO; KANG-YI SU; SUNG-LIANG YU; Huang, Yen Lin; CHONG-JEN YU; Chih-Hsin Yang, James; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-07-15T05:32:06Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 中山醫學大學 |
2021-06-08 |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Yen-Hsiang Huang; Jeng-Sen Tseng; Kuo-Hsuan Hsu; Kun-Chieh Chen; Kang-Yi Su; Sung-Liang Yu; Jeremy J. W. Chen; Tsung-Ying Yang ; Gee-Chen Chang |
顯示項目 11-20 / 85 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
